Day 2 Program

Educational Session 6: ADCs in the Clinic

Day 2: December 10, 2025

2:30 PM–4:15 PM CST

Stars at Night 1-2

Session Details

This session will explore the evolving role of antibody-drug conjugates (ADCs) in breast cancer care, covering their use in early-stage disease, optimal sequencing in metastatic settings, and activity in patients with brain metastases, with perspectives from clinical experts and patient advocates.

ED6-01

Moving on up: ADCs in early-stage breast cancer

Sibylle Loibl, Goethe University of Frankfurt, Frankfurt, Germany

ED6-02

Positioning and sequencing of ADCs in metastatic breast cancer

Reshma L Mahtani, Baptist Health Miami Cancer Institute, Miami, FL

ED6-03

Activity of ADCs in patients with brain metastases

Andrew J Brenner, University of Texas Health Science Center at San Antonio, San Antonio, TX

Advocate

Rosa Olmos, Con Cáncer y Con Metas, Barcelona, Spain